Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemia

Detalhes bibliográficos
Autor(a) principal: Pascotini, Eduardo Tanuri
Data de Publicação: 2015
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/17373
Resumo: Stroke occurs when blood flow to the brain is interrupted by an embolic or thrombotic occlusion of a cerebral artery (ischemic stroke) or by bleeding from a ruptured blood vessel (hemorrhagic stroke). Oxidative stress and brain inflammation are thought to contribute to the pathophysiology of cerebral injury in acute stroke, leading to apoptosis and cell death. Lipid accumulation may lead to progression of carotid plaques and inflammation, contributing to increased acute stroke risk. However, little is known about these events and markers in the late stroke (> 6 months) and if dyslipidemia could contribute to disease pathophysiology in a later phase. In this case-control study, we recruited stroke patients (n=40) and health subjects (control group; n=40). Dichlodihidrorofluorescin (DCFH), nitrite/nitrate (NOx), Tumor necrosis factor – alpha (TNF-α), Acetylcholinesterase (AChE), Caspase 8 (CASP 8), Caspase 3 (CASP 3) and Picogreen (PG) were measured in periphery blood samples. Furthermore, a correlation among all measured markers (DCFH, NOx, TNF-α, AChE, CASP 8, CASP 3 and PG) was realized. The markers levels were also compared to triglycerides (TG), total (CHO), LDL and HDL cholesterol levels and medications used. Statistical analyses showed that stroke patients presented an increase of DCFH, NOx, TNF-α and AChE levels when compared to control subjects. In addition, we observed that stroke patients had significantly higher CASP 8, CASP 3 and PG levels than control group. A significant correlation between TNF-α with CASP 8 (r = 0.4) and CASP 3 (r = 0.4) levels was observed, but not with oxidative/nitrosative markers. Moreover, we observed that stroke patients with dyslipidemia had significantly higher TNF-α, CASP 8 and CASP 3 levels than stroke without dyslipidemia and control groups. Our findings suggest that oxidative and inflammatory markers may be still increased and lead to caspases activation and DNA damage even after 6 months to cerebral injury. Furthermore, it is plausible to propose that dyslipidemia may contribute to worsen proinflammatory state in a later phase of stroke and an increased risk to new neurovascular events.
id UFSM_62db98ad626b8be075caf8bc2ab77eb8
oai_identifier_str oai:repositorio.ufsm.br:1/17373
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemiaInflamatory and apoptotic pathways association in a later phase of stroke pathophysiology: relation to dyslipidemiaAcidente vascular encefálicoEstresse oxidativoInflamaçãoCaspasesDano ao DNA e dislipidemiaStrokeOxidative stressInflammationCaspasesDNA damageDyslipidemiaCNPQ::CIENCIAS DA SAUDE::FARMACIAStroke occurs when blood flow to the brain is interrupted by an embolic or thrombotic occlusion of a cerebral artery (ischemic stroke) or by bleeding from a ruptured blood vessel (hemorrhagic stroke). Oxidative stress and brain inflammation are thought to contribute to the pathophysiology of cerebral injury in acute stroke, leading to apoptosis and cell death. Lipid accumulation may lead to progression of carotid plaques and inflammation, contributing to increased acute stroke risk. However, little is known about these events and markers in the late stroke (> 6 months) and if dyslipidemia could contribute to disease pathophysiology in a later phase. In this case-control study, we recruited stroke patients (n=40) and health subjects (control group; n=40). Dichlodihidrorofluorescin (DCFH), nitrite/nitrate (NOx), Tumor necrosis factor – alpha (TNF-α), Acetylcholinesterase (AChE), Caspase 8 (CASP 8), Caspase 3 (CASP 3) and Picogreen (PG) were measured in periphery blood samples. Furthermore, a correlation among all measured markers (DCFH, NOx, TNF-α, AChE, CASP 8, CASP 3 and PG) was realized. The markers levels were also compared to triglycerides (TG), total (CHO), LDL and HDL cholesterol levels and medications used. Statistical analyses showed that stroke patients presented an increase of DCFH, NOx, TNF-α and AChE levels when compared to control subjects. In addition, we observed that stroke patients had significantly higher CASP 8, CASP 3 and PG levels than control group. A significant correlation between TNF-α with CASP 8 (r = 0.4) and CASP 3 (r = 0.4) levels was observed, but not with oxidative/nitrosative markers. Moreover, we observed that stroke patients with dyslipidemia had significantly higher TNF-α, CASP 8 and CASP 3 levels than stroke without dyslipidemia and control groups. Our findings suggest that oxidative and inflammatory markers may be still increased and lead to caspases activation and DNA damage even after 6 months to cerebral injury. Furthermore, it is plausible to propose that dyslipidemia may contribute to worsen proinflammatory state in a later phase of stroke and an increased risk to new neurovascular events.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPESO Acidente Vascular Encefálico (AVE) é caracterizado pela perda rápida da função neurológica por uma isquemia ou hemorragia cerebral. No AVE isquêmico, o estresse oxidativo e a neuroinflamação contribuem para a patofisiologia do dano cerebral, conduzindo a apoptose e morte celular. A dislipidemia é considerada um dos principais fatores de risco para o desenvolvimento do AVE, induzindo a aterogênese e inflamação, aumentando as chance de novos eventos vasculares agudos. Entretanto, são escassos os estudos sobre estes eventos na fase tardia (>6 meses) do AVE e se a dislipidemia pode contribuir para a patofisiologia nesta fase da doença. O presente estudo teve como objetivo investigar se existe uma associação entre a via inflamatória e apoptótica, bem como, um envolvimento do dano oxidativo e da dislipidemia nas amostras sanguíneas de pacientes com AVE na fase tardia. Este foi um estudo caso-controle, onde 40 pacientes que sofreram AVE (Grupo AVE) e 40 sujeitos saudáveis (Grupo Controle) foram recrutados a realizar uma coleta de sangue e preenchimento de um questionário clínico. Foram mensurados os seguintes marcadores: Diclorodihidrofluorosceína (DCF), Nitrito/Nitrato (NOx), Fator de necrose tumoral alfa (TNF-α), Acetilcolinterterase (AChE), Caspase 8 (CASP 8), Caspase 3 (CASP 3) e Picogreen (PG), em amostras sanguíneas da circulação periférica. Além disso, foram realizadas correlações entre DCF, NOx, TNF-α, AChE, CASP 8, CASP 3 e PG com os grupos do estudo. Os níveis dos marcadores também foram comparados com indicadores de perfil lipídico como: triglicerídeos (TG), colesterol total (CT), LDL e HDL e o perfil medicamentoso. As análises estatísticas mostraram que os pacientes pós-AVE apresentaram níveis aumentados de DCF (p<0,0001), NOx (p<0,0001), TNF-α (p<0,0001) e AChE (p<0,0001), assim como, CASP 8 (p<0,0001), CASP 3 (p<0,0001) e PG (p<0,0001) quando comparados ao controle. Uma correlação positiva foi observada entre os níveis de TNF-α com a CASP 8 (r = 0,4 ; p<0,05) e CASP 3 (r = 0,4 ; p<0,05), porém quando comparado aos níveis oxidativos/nitrosativos não houve correlação. Além disso, o estudo mostrou que os pacientes pós-AVE dislipidêmicos (AVEd) apresentaram níveis significativamente elevados de TNF-α, CASP 8 e CASP 3, quando comparados com os pacientes pós-AVE sem dislipidemia (AVEnd) e com o grupo controle. Desta forma, os resultados sugerem que os marcadores oxidativos e inflamatórios podem estar aumentados mesmo na fase crônica do AVE, e culminarem na ativação das caspases (apoptose) e consequente dano ao DNA. Assim, é plausível propor que a dislipidemia na fase tardia do AVE pode contribuir para a piora do quadro inflamatório e aumentar o risco de novos eventos neurovasculares.Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em FarmacologiaCentro de Ciências da SaúdeFighera, Michele Rechiahttp://lattes.cnpq.br/8583392747509231Santos, Adair Roberto Soares doshttp://lattes.cnpq.br/9263042062534666Stigger, Felipe de Souzahttp://lattes.cnpq.br/8472687293029599Pascotini, Eduardo Tanuri2019-07-09T21:50:22Z2019-07-09T21:50:22Z2015-01-22info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/17373porAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2019-07-10T06:01:40Zoai:repositorio.ufsm.br:1/17373Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2019-07-10T06:01:40Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemia
Inflamatory and apoptotic pathways association in a later phase of stroke pathophysiology: relation to dyslipidemia
title Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemia
spellingShingle Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemia
Pascotini, Eduardo Tanuri
Acidente vascular encefálico
Estresse oxidativo
Inflamação
Caspases
Dano ao DNA e dislipidemia
Stroke
Oxidative stress
Inflammation
Caspases
DNA damage
Dyslipidemia
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemia
title_full Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemia
title_fullStr Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemia
title_full_unstemmed Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemia
title_sort Associação da via inflamatória e apoptótica na patofisiologia do acidente vascular encefálico tardio: relação com a dislipidemia
author Pascotini, Eduardo Tanuri
author_facet Pascotini, Eduardo Tanuri
author_role author
dc.contributor.none.fl_str_mv Fighera, Michele Rechia
http://lattes.cnpq.br/8583392747509231
Santos, Adair Roberto Soares dos
http://lattes.cnpq.br/9263042062534666
Stigger, Felipe de Souza
http://lattes.cnpq.br/8472687293029599
dc.contributor.author.fl_str_mv Pascotini, Eduardo Tanuri
dc.subject.por.fl_str_mv Acidente vascular encefálico
Estresse oxidativo
Inflamação
Caspases
Dano ao DNA e dislipidemia
Stroke
Oxidative stress
Inflammation
Caspases
DNA damage
Dyslipidemia
CNPQ::CIENCIAS DA SAUDE::FARMACIA
topic Acidente vascular encefálico
Estresse oxidativo
Inflamação
Caspases
Dano ao DNA e dislipidemia
Stroke
Oxidative stress
Inflammation
Caspases
DNA damage
Dyslipidemia
CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Stroke occurs when blood flow to the brain is interrupted by an embolic or thrombotic occlusion of a cerebral artery (ischemic stroke) or by bleeding from a ruptured blood vessel (hemorrhagic stroke). Oxidative stress and brain inflammation are thought to contribute to the pathophysiology of cerebral injury in acute stroke, leading to apoptosis and cell death. Lipid accumulation may lead to progression of carotid plaques and inflammation, contributing to increased acute stroke risk. However, little is known about these events and markers in the late stroke (> 6 months) and if dyslipidemia could contribute to disease pathophysiology in a later phase. In this case-control study, we recruited stroke patients (n=40) and health subjects (control group; n=40). Dichlodihidrorofluorescin (DCFH), nitrite/nitrate (NOx), Tumor necrosis factor – alpha (TNF-α), Acetylcholinesterase (AChE), Caspase 8 (CASP 8), Caspase 3 (CASP 3) and Picogreen (PG) were measured in periphery blood samples. Furthermore, a correlation among all measured markers (DCFH, NOx, TNF-α, AChE, CASP 8, CASP 3 and PG) was realized. The markers levels were also compared to triglycerides (TG), total (CHO), LDL and HDL cholesterol levels and medications used. Statistical analyses showed that stroke patients presented an increase of DCFH, NOx, TNF-α and AChE levels when compared to control subjects. In addition, we observed that stroke patients had significantly higher CASP 8, CASP 3 and PG levels than control group. A significant correlation between TNF-α with CASP 8 (r = 0.4) and CASP 3 (r = 0.4) levels was observed, but not with oxidative/nitrosative markers. Moreover, we observed that stroke patients with dyslipidemia had significantly higher TNF-α, CASP 8 and CASP 3 levels than stroke without dyslipidemia and control groups. Our findings suggest that oxidative and inflammatory markers may be still increased and lead to caspases activation and DNA damage even after 6 months to cerebral injury. Furthermore, it is plausible to propose that dyslipidemia may contribute to worsen proinflammatory state in a later phase of stroke and an increased risk to new neurovascular events.
publishDate 2015
dc.date.none.fl_str_mv 2015-01-22
2019-07-09T21:50:22Z
2019-07-09T21:50:22Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/17373
url http://repositorio.ufsm.br/handle/1/17373
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1805922129970987008